Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-02-23 @ 8:08 PM
Study NCT ID:
NCT05877820
Status:
RECRUITING
Last Update Posted:
2023-08-31
First Post:
2023-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCC
Sponsor:
RenJi Hospital
Organization: